CDIO
NASDAQ · Biotechnology
Cardio Diagnostics Holdings
$2.08
+0.07 (+3.48%)
Open$2.01
Previous Close$2.01
Day High$2.10
Day Low$1.97
52W High$7.91
52W Low$0.97
Volume—
Avg Volume39.7K
Market Cap5.95M
P/E Ratio—
EPS$-3.38
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,488.0% upside
Current
$2.08
$2.08
Target
$33.03
$33.03
$21.42
$33.03 avg
$37.66
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 25.2K | 758.5K | 743.9K |
| Net Income | -10,980,220 | -209,998 | -203,473 |
| Profit Margin | -43,817.7% | -27.7% | -27.4% |
| EBITDA | -10,846,156 | -263,366 | -243,311 |
| Free Cash Flow | — | -217,938 | -231,433 |
| Rev Growth | — | -7.2% | +1.3% |
| Debt/Equity | 0.04 | 0.72 | 0.58 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $254.31 | +0.38% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $360.55 | +0.62% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.33 | -1.21% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $499.65 | +1.69% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $631.81 | -0.17% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $293.52 | +0.74% | 69.3 | 39.97B |